Your browser doesn't support javascript.
loading
Steps toward Maturation of Embryonic Stem Cell-Derived Cardiomyocytes by Defined Physical Signals.
Shen, Nian; Knopf, Anne; Westendorf, Claas; Kraushaar, Udo; Riedl, Julia; Bauer, Hannah; Pöschel, Simone; Layland, Shannon Lee; Holeiter, Monika; Knolle, Stefan; Brauchle, Eva; Nsair, Ali; Hinderer, Svenja; Schenke-Layland, Katja.
Afiliación
  • Shen N; Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart 70569, Germany; Department of Women's Health, Research Institute of Women's Health, University Hospital of the Eberhard Karls University Tübingen, Tübingen 72076, Germany.
  • Knopf A; Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart 70569, Germany; Department of Women's Health, Research Institute of Women's Health, University Hospital of the Eberhard Karls University Tübingen, Tübingen 72076, Germany.
  • Westendorf C; Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart 70569, Germany.
  • Kraushaar U; Department of Cell Biology, Electrophysiology, Natural and Medical Sciences Institute, University of Tübingen, Reutlingen 72770, Germany.
  • Riedl J; Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart 70569, Germany; Department of Women's Health, Research Institute of Women's Health, University Hospital of the Eberhard Karls University Tübingen, Tübingen 72076, Germany.
  • Bauer H; Department of Women's Health, Research Institute of Women's Health, University Hospital of the Eberhard Karls University Tübingen, Tübingen 72076, Germany.
  • Pöschel S; Department of Women's Health, Research Institute of Women's Health, University Hospital of the Eberhard Karls University Tübingen, Tübingen 72076, Germany.
  • Layland SL; Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart 70569, Germany; Department of Women's Health, Research Institute of Women's Health, University Hospital of the Eberhard Karls University Tübingen, Tübingen 72076, Germany.
  • Holeiter M; Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart 70569, Germany; Department of Women's Health, Research Institute of Women's Health, University Hospital of the Eberhard Karls University Tübingen, Tübingen 72076, Germany.
  • Knolle S; Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart 70569, Germany; Department of Cell Biology, Electrophysiology, Natural and Medical Sciences Institute, University of Tübingen, Reutlingen 72770, Germany.
  • Brauchle E; Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart 70569, Germany; Department of Women's Health, Research Institute of Women's Health, University Hospital of the Eberhard Karls University Tübingen, Tübingen 72076, Germany.
  • Nsair A; Department of Medicine/Cardiology, Cardiovascular Research Laboratories (CVRL), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA; Broad Stem Cell Research Center, David School of Medicine at UCLA, Los Angeles, CA 90095, USA.
  • Hinderer S; Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart 70569, Germany; Department of Women's Health, Research Institute of Women's Health, University Hospital of the Eberhard Karls University Tübingen, Tübingen 72076, Germany.
  • Schenke-Layland K; Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart 70569, Germany; Department of Women's Health, Research Institute of Women's Health, University Hospital of the Eberhard Karls University Tübingen, Tübingen 72076, Germany; Dep
Stem Cell Reports ; 9(1): 122-135, 2017 07 11.
Article en En | MEDLINE | ID: mdl-28528699
Cardiovascular disease remains a leading cause of mortality and morbidity worldwide. Embryonic stem cell-derived cardiomyocytes (ESC-CMs) may offer significant advances in creating in vitro cardiac tissues for disease modeling, drug testing, and elucidating developmental processes; however, the induction of ESCs to a more adult-like CM phenotype remains challenging. In this study, we developed a bioreactor system to employ pulsatile flow (1.48 mL/min), cyclic strain (5%), and extended culture time to improve the maturation of murine and human ESC-CMs. Dynamically-cultured ESC-CMs showed an increased expression of cardiac-associated proteins and genes, cardiac ion channel genes, as well as increased SERCA activity and a Raman fingerprint with the presence of maturation-associated peaks similar to primary CMs. We present a bioreactor platform that can serve as a foundation for the development of human-based cardiac in vitro models to verify drug candidates, and facilitates the study of cardiovascular development and disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Técnicas de Cultivo de Célula / Reactores Biológicos / Miocitos Cardíacos / Células Madre Embrionarias Humanas / Células Madre Embrionarias de Ratones Límite: Animals / Humans Idioma: En Revista: Stem Cell Reports Año: 2017 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Técnicas de Cultivo de Célula / Reactores Biológicos / Miocitos Cardíacos / Células Madre Embrionarias Humanas / Células Madre Embrionarias de Ratones Límite: Animals / Humans Idioma: En Revista: Stem Cell Reports Año: 2017 Tipo del documento: Article País de afiliación: Alemania